Orchestra Biomed Holdings, Inc.盘中异动股价大跌5.02%报5.30美元_老虎社区_美港股上老虎

Orchestra Biomed Holdings, Inc.盘中异动股价大跌5.02%报5.30美元

市场透视12-05

北京时间2024年12月05日04时15分，Orchestra Biomed Holdings, Inc.（OBIO.us）股票出现异动，股价快速下跌5.02%。截至发稿，该股报5.30美元/股，成交量1.143万股，换手率0.03%，振幅5.29%。最近的财报数据显示，该股实现营业收入987000.00美元，净利润-15.43百万美元，每股收益-0.41美元，毛利843000.00美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2489144071?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-05 04:15","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2489144071","market":"us","top_or_hot":-1,"title":"Orchestra Biomed Holdings, Inc.盘中异动 股价大跌5.02%报5.30美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月05日04时15分，Orchestra Biomed Holdings, Inc.（OBIO.us）股票出现异动，股价快速下跌5.02%。截至发稿，该股报5.30美元/股，成交量1.143万股，换手率0.03%，振幅5.29%。最近的财报数据显示，该股实现营业收入987000.00美元，净利润-15.43百万美元，每股收益-0.41美元，毛利843000.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205041532971bae9e&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orchestra Biomed Holdings, Inc.盘中异动 股价大跌5.02%报5.30美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrchestra Biomed Holdings, Inc.盘中异动 股价大跌5.02%报5.30美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-05 04:15 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205041532971bae9e&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月05日04时15分，Orchestra Biomed Holdings, Inc.（OBIO.us）股票出现异动，股价快速下跌5.02%。截至发稿，该股报5.30美元/股，成交量1.143万股，换手率0.03%，振幅5.29%。最近的财报数据显示，该股实现营业收入987000.00美元，净利润-15.43百万美元，每股收益-0.41美元，毛利843000.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205041532971bae9e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OBIO","symbol_name":"Orchestra BioMed","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205041532971bae9e&s=b","article_id":"2489144071","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205041532971bae9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2489144071","pubTimestamp":1733343331,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月05日04时15分，Orchestra Biomed Holdings, Inc.股票出现异动，股价快速下跌5.02%。Orchestra Biomed Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Orchestra Biomed Holdings, Inc.公司简介：Orchestra BioMed Holdings Inc 是一家生物医学创新公司，通过风险回报共享合作伙伴关系加速为患者提供高影响力技术。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"OBIO":"Orchestra BioMed","BK4082":"医疗保健设备"},"translate_title":"Orchestra Biomed Holdings, Inc. shares fell 5.02% to $5.30 in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OBIO":0.9},"content_text":"北京时间2024年12月05日04时15分，Orchestra Biomed Holdings, Inc.（OBIO.us）股票出现异动，股价快速下跌5.02%。截至发稿，该股报5.30美元/股，成交量1.143万股，换手率0.03%，振幅5.29%。最近的财报数据显示，该股实现营业收入987000.00美元，净利润-15.43百万美元，每股收益-0.41美元，毛利843000.00美元，市盈率-3.38倍。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Orchestra Biomed Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Exicure, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为4984.52%、287.60%、146.65%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Cyclerion Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028(To Pur Com)，振幅分别为548.98%、301.86%、64.57%。Orchestra Biomed Holdings, Inc.公司简介：Orchestra BioMed Holdings Inc 是一家生物医学创新公司，通过风险回报共享合作伙伴关系加速为患者提供高影响力技术。 其基于合作伙伴关系的商业模式侧重于与医疗设备公司建立战略合作，以推动其开发产品的全球商业化。该公司的旗舰候选产品包括用于治疗高血压的 BackBeat 心脏神经调节疗法 (CNT) 和用于治疗动脉粥样硬化性动脉疾病的 Virtue Sirolimus AngioInfusionBalloon (SAB)。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}